Scientific Program

Filter Results:

  • +

    IASLC Supporting the Implementation of Quality Assured Global CT Screening Workshop (By Invitation Only) (ID 632)

    • 08:30 AM - 09:00 PM
    • 10/14/2017
    • Type: Educational Session
    • Track: Radiology/Staging/Screening
    • Moderators:
    • +

      Welcome and Aims of Workshop (ID 10613)

      James Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 1 (ID 10640)

      John Kirkpatrick Field

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      CT Screened Lung Cancer Survivor: A Patients Prospective on Lung Cancer Screening (ID 10641)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tobacco Cessation in the CT Screening Setting – Is It Working? (ID 10642)

      Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How Do We Engage the High Risk Population in Lung Cancer Screening? - Primary Care Perspective in UK (ID 10643)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How Do We Engage the High Risk Population in Lung Cancer Screening? - Strategy for Engaging Participants (ID 10644)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Modeling Smoking Trends and CT Screening to 2060 (ID 10645)

      Rafael Meza

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Discussion (ID 10646)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 2: Radiological Imaging – Quality Assurance and Training (ID 10647)

      David Raymond Baldwin

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Reviews of International Guidelines for Management of Pulmonary Nodules (i.e. NCCN/ LUNG-RADS, BTS, Fleischner IELCAP, etc.) (ID 10648)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Planning for European Registries for CT Screened Images – What Are Their Objectives? (ID 10649)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Planning for USA Registries for CT Screened Images – What Are Their Objectives? (ID 10650)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Next Generation CT Scanners for Lung Cancer Screening – Way Forward (ID 10651)

      Sebastian Schmidt

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Discussion (ID 10652)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tea/Coffee Break (ID 10653)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 3: Added Value to Lung Cancer CT Screening Programs (ID 10654)

      Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Potential of Radio-omics and Deep Learning (ID 10655)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Indicator Detection Trial (LuCID) (ID 10656)

      Marc Van Der Schee

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Cardiologists View of Utilising Calcium Scoring in Lung Cancer Screening Trials (ID 10657)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lunch (ID 10658)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 4: The Concept of Collaboration in CT Screening Programs (ID 10659)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Quality Control Throughout Lung Cancer Management (ID 10662)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Radiology Leading But Integrated? (ID 10664)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Designs of Possible Biomarkers for Future Screening Programs? (ID 10665)

      John Kirkpatrick Field

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Smoking Cessation – How to Integrate? (ID 10670)

      Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      COPD Integration into CT Screening – Patient Benefit? (ID 10671)

      Javier Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Surgical Integration at the Earliest Stages Planned CT Screening? (ID 10672)

      Jesper Holst Pedersen

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Discussion (ID 10673)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 5: The Current Global Implementation of CT Lung Cancer Screening Programs (ID 10674)

      Shuji Sakai

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      China (ID 10675)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Japan (ID 10676)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Canada & Australia (ID 10677)

      Kwun Fong

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      EU Commission Recommendations on Screening (ID 10678)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      CT Screening in USA – Current Issues around Implementation – Lessons to be Learnt (ID 10679)

      James Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      USA Roundtable Update (ID 10680)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      NELSON – Update (ID 10681)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tea/Coffee Break (ID 10682)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 6: What Priorities and Recommendations Should the IASLC Executive Focus On: How They Can Support Leadership in this Area of Lung Cancer (Round Table Discussion) (ID 10683)

      James Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      1. How Do We Ensure Smoking Cessation is Integrated into Best Practice Screening? (ID 10684)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      2. How Do We Optimise an International Approach to Pulmonary Nodules Management? (ID 10685)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      3. How to Talk About Lung Cancer Screening Which is More Appropriate to the Public? (ID 10686)

      Sam M Janes

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      4. Can we Implement International Standards for Quantitative CT Imaging within Lung Cancer? (ID 10687)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      5. How Can IASLC Lead Global Lung Cancer Progress Over the Next 10 Years? (ID 10688)

      Kwun Fong

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Networking Dinner (ID 10689)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    IASLC Symposium on the Advances in Lung Cancer CT Screening (Ticketed Session) (ID 631)

    • 09:00 AM - 06:15 PM
    • 10/14/2017
    • Type: Symposium
    • Track: Radiology/Staging/Screening
    • Moderators:
    • +

      Welcome to the Special Symposium (ID 10583)

      Claudia I Henschke

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 1: Status of Lung Cancer Screening in USA and Europe (ID 10584)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Screening – IELCAP Contribution to CT Screening Implementation (ID 10620)

      Claudia I Henschke

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Screening Status in Europe (ID 10621)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The European Commission Recommendations on Lung Cancer Screening (ID 10622)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Group Discussion (ID 10623)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tea/Coffee Break (ID 10585)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 2: Current Lung Cancer Screening Guidelines (Panel Discussion) (ID 10586)

      Javier Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Guidelines (ID 10624)

      Sadayuki Murayama

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lunch (ID 10587)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 3: Early Detection Biomarkers (ID 10588)

      Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Biomarkers - Do We Have Good Candidates for Early Detection? (ID 10625)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      New Approaches to Interventional Pulmonology for Lung Cancer Screening (ID 10626)

      Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Airway Transcriptome (ID 10627)

      Avrum Spira

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Quality Control for Lung Imaging Biomarkers (ID 10628)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tea/Coffee Break (ID 10589)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Session 4: Lung Cancer Screening’s Impact on COPD and Smoking Cessation (ID 10590)

      Andrea Katalin Borondy Kitts

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Lung Cancer Screening and COPD – A Pneumologist’s Viewpoint (ID 10629)

      Javier Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Tobacco Cessation in the CT Screening Setting – The Way Forward? (ID 10630)

      Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Communicating Complex Issues Simply: Pivotal Role of Nursing in Lung Cancer Screening (ID 10631)

      Joelle T Fathi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Final Discussion (ID 10632)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    Joint Session IASLC/CSCO/CAALC: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West (ID 630)

    • 07:30 AM - 11:30 AM
    • 10/15/2017
    • Type: Joint Session IASLC/CSCO/CAALC
    • Track: Immunology and Immunotherapy
    • Moderators:
    • +

      Breakfast and Poster Viewing (ID 8221)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Welcome and Introduction (ID 8222)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Science of Immunotherapy (ID 8220)

      Roy Herbst

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Predictive Biomarkers for Checkpoint Inhibitors from Chinese Studies (ID 8223)

      Yong Song

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      PD-1+CD8+ T and iNKT Cell Based Immunotherapy on Lung Cancer (ID 8224)

      Jianqing Xu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ctDNA Based Tumor Mutation Burden Evaluation for Predicting Immunotherapy Effect (ID 8225)

      Jie Hu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Ongoing Trials in China on Checkpoint Inhibitors and Other Immunotherapies (ID 8226)

      Qing Zhou

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Coffee Break and Poster Viewing (ID 8227)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Therapeutic Practices in Europe for Immunotherapy, including Biomarkers (ID 8228)

      Solange Peters

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Abstract Presentations from China Related to Immunotherapy (ID 8229)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Closing Remarks (ID 8230)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    YI - Young Investigator and First Time Attendee Session (ID 588)

    • 08:00 AM - 11:30 AM
    • 10/15/2017
    • Type: Young Investigator
    • Track: Education/Publication/Career Development
    • Moderators:
    • +

      Introduction to IASLC: What It Can Do For You (ID 7845)

      Silvia Novello

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Planning an Academic Career in Lung Cancer (ID 7846)

      Navneet Singh

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Community versus Academic Oncology (ID 7847)

      Philip Bonomi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Clinical Trials 101 (ID 7848)

      Julie R Brahmer

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Investigator Initiated Trials (ID 7849)

      Daniel SW Tan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Coffee Break (ID 8130)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How to Get Your Paper Published (ID 7850)

      Alex Adjei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Why Should I Publish? An Overview of the Manuscript Cycle: From Submission to Publication (ID 7851)

      James Jett

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How to Prepare an Abstract for an International Conference and How to Prepare Your Presentation for the Conference (Tips and Tricks) (ID 7852)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How to Write a Grant Application for Young Investigators (ID 7853)

      Heather A Wakelee

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Young Investigator Travel Award Experience - A Report from a Previous Award Winners (ID 7854)

      Takahiro Karasaki

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Making the Most of the WCLC: A Guide for First Time Attendee - From an Expert Perspective (ID 7855)

      Suresh Senan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Making the Most of the WCLC: A Guide for First Time Attendee - From a Second Time Attendee (ID 7856)

      Deepali Jain

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    Press Conference (ID 646)

    • 10:15 AM - 11:15 AM
    • 10/15/2017
    • Type: Press Conference
    • Track:
    • Moderators:
    • +

      Press Conference (ID 10756)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 01 - Treatment Options for Patients with ALK+ NSCLC: How is the Paradigm Changing? - Takeda (ID 634)

    • 11:30 AM - 01:00 PM
    • 10/15/2017
    • Type: Industry Supported Symposium
    • Track:
    • Moderators:
    • +

      Welcome and Introduction (ID 10615)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The changing Treatment Landscape for ALK+ NSCLC: What's New? (ID 10616)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Long-term Survival for Patients with ALK+ NSCLC: An Achievable Aim? (ID 10617)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Testing resistant ALK+ NSCLC: can treatment be personalised? (ID 10618)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Summary and Conclusions (ID 10619)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 03 - Treatment Selection Strategies in Advanced NSCLC – Implications and Global Perspectives - Lilly (ID 635)

    • 03:00 PM - 04:30 PM
    • 10/15/2017
    • Type: Industry Supported Symposium
    • Track:
    • Moderators:
    • +

      Welcome & Introduction (ID 10633)

      Kazuhiko Nakagawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The importance of different therapeutic approaches to maximise patient outcomes (ID 10634)

      David R. Gandara

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      How long do I treat? When to stop? Implications for clinical practice (ID 10635)

      Silvia Novello

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Illustrative and interactive case study discussions (ID 10636)

      Myung-Ju Ahn

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Global perspectives on the changing treatment paradigm in advanced NSCLC (ID 10637)

      James Chih-Hsin Yang

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Panel Discussion (ID 10638)

      Kazuhiko Nakagawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Symposium Closes (ID 10639)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 04 - Management of Advanced NSCLC: Where Do Immune Checkpoint Inhibitors Fit In? - AstraZeneca (ID 636)

    • 04:45 PM - 06:15 PM
    • 10/15/2017
    • Type: Industry Supported Symposium
    • Track:
    • Moderators:
    • +

      Welcome and Introductions (ID 10690)

      Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Where Do Checkpoint Inhibitors Fit in Second-Line Therapy? (ID 10691)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Where Do Checkpoint Inhibitors Fit in First-Line Therapy? (ID 10692)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Immune Effects of Immune Checkpoint Inhibitors: ir-AEs (ID 10693)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Double, Double, Toil and Trouble With Combination Therapy? (ID 10694)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      The Future of Checkpoint Inhibitors in Your Practice (ID 10695)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Concluding Remarks (ID 10696)

      Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      Question and Answer Session (ID 10697)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    Opening Ceremony (ID 648)

    • 06:30 PM - 08:00 PM
    • 10/15/2017
    • Type: Networking Opportunity
    • Track:
    • Moderators:
    • +

      Opening Ceremony (ID 10743)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    Welcome Reception (ID 649)

    • 08:00 PM - 09:00 PM
    • 10/15/2017
    • Type: Networking Opportunity
    • Track:
    • Moderators:
    • +

      Welcome Reception (ID 10744)

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review